Detecting Pathogens.
Advancing Possibilities.

Infectious diseases affect people, families, and communities.

NGS assay-losange- source-2 copy 5

To limit the burden of infections, especially when associated with host immune disorders, mean diagnosis, and treatment at the molecular level.

Complementing our expertise in PCR and NGS assay development are working relationships with more than 1,000 medical providers who have performed over 3 million patient tests with Acutis.

Our scientific knowledge base in immunology and infectious disease supports full drug and IVD device development from discovery through registration and lifecycle management.


“The most advanced science without a service-first mindset is the proverbial cart ahead of the horse. Powered by science, we are a service-led organization.”

CEO, Acutis Diagnostics
Jibreel Sarij

image-testimonials jibreel 2

Detection, Profiling, Monitoring, and More

biomarker-losange- source-contrasted2 copy

From traditional microbiology and biomarker-driven companion diagnostics to next-generation assays—we’re at your service.

Broad capabilities in bacteriology, virology, mycology, and parasitology generate robust data that inform rich genetic insights for FDA approvals and one-of-a-kind genetic panels, including assays approved by the New York Department of Health.

  • Flexible work capacity for ease of scalability during peak infection seasons

  • Deep expertise in qPCR, dPCR, and NGS-based assays and analytics

  • Medical provider relationships spanning diverse geographies and demographics

With noninvasive urinary, serologic, saliva, and lesion infectious disease sample collection, we help to minimize the impact of study participation on patients.


"We provide an edge to our biopharma and IVD device partners with state-of-the-art technologies for diagnosing infectious agents and assessing microbe-host interactions.”

Chief Scientific Officer, Executive Vice President, Biopharma and Diagnostic Services
Dr. Abdel Halim

image-testimonials halim -3

Gold Standard and Cutting-Edge Technologies

Sophisticated microbiology assay designs for detection and characterization


Multiplex PCR assay with >14 major bacterial, viral and parasitic gastrointestinal pathogens, including Clostridium difficile toxins A and B.
> Learn more

Urinary Tract Infection

Multiplex PCR assay with >30 bacterial and fungal pathogens, including organisms that are difficult to grow in traditional culture.
> Learn more

Upper Respiratory Infection

Multiplex PCR assay with >22 major viral and bacterial respiratory pathogens.
> Learn more


Multiple assays, including rNaseP detection.

Next-generation sequencing of the virus on the Illumina NovaSeq 6000.
> Learn more

Sexually Transmitted Infections

Multiple serology and swab assays using PCR in combination with other techniques.
> Learn more


PCR assay based on the most current CDC guideline

Wound Infection

Multiplex PCR assay with >37 bacterial and fungal pathogens

Women’s Health Panel

Multiplex PCR assay with >31 bacterial and fungal pathogens

Antibiotic-Resistant Gene Assay

Broad PCR assay to detect resistance genes associated with common bacterial infections
, such as urinary tract and wound infections.

Healthcare-Associated Infections

Comprehensive culture-based organism detection and antimicrobial sensitivity with a broad array using multiple platforms, highlighted by our unique “PCR-Guided AST”.

Broad-Set Panels for Immunological Response Assessments

  • Flow cytometry for CD3/CD4 and other human immune cell subclasses

  • Cytokines/inflammatory panel(s), including:
        - serum IL-1, IL-6, IL-8, IL-10, IL-12, IL-18, TNF-a,
           IFN-g, CD14, CRP, procalcitonin, NT-proBNP
      and endothelial cell-surface adhesion molecules:   
        - sE-selectin, sICAM-1 and sVCAM-1.
  • Coagulopathy biomarkers, including:
      - PT, aPTT, and D-dimer
  • TSH and other key hormones

  • Full hematology capabilities, including:
      - complete blood count with differential and platelets


At The Service of Science